These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 15196059)

  • 21. The acceptable reactive crossmatch (ARC), post-transplant monitoring, and their impact on kidney transplantation: a single center experience.
    Leone JP; Bowers V; Baliga R; Sanders C; LeFor W; Becker D; Thompson D; Resto-Ruiz S; Lopez-Cepero M
    Clin Transpl; 2011; ():373-9. PubMed ID: 22755434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of bortezomib on donor specific antibody reduction in patients with antibody mediated rejection.
    Hardinger KL; Murillo D
    Clin Transpl; 2011; ():401-8. PubMed ID: 22755438
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention and treatment of alloantibody-mediated kidney transplant rejection.
    Bartel G; Schwaiger E; Böhmig GA
    Transpl Int; 2011 Dec; 24(12):1142-55. PubMed ID: 21831227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 7th International Immunoglobulin Conference: Transplantation.
    Jordan SC; Glotz D
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):46-7. PubMed ID: 25546758
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.
    Montgomery RA; Zachary AA; Racusen LC; Leffell MS; King KE; Burdick J; Maley WR; Ratner LE
    Transplantation; 2000 Sep; 70(6):887-95. PubMed ID: 11014642
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Summary of FDA antibody-mediated rejection workshop.
    Archdeacon P; Chan M; Neuland C; Velidedeoglu E; Meyer J; Tracy L; Cavaille-Coll M; Bala S; Hernandez A; Albrecht R
    Am J Transplant; 2011 May; 11(5):896-906. PubMed ID: 21521465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of recipients of human leukocyte antigen incompatible kidney transplants who underwent desensitization at King Fahad Specialist Hospital, Dammam, Saudi Arabia.
    Idris MA; Hossain A; Muntasir MA; Marmi A; Aldajani AA; Aljamaan YM; Akhtar M; Housawi A
    Saudi J Kidney Dis Transpl; 2017; 28(3):499-506. PubMed ID: 28540885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted monitoring of donor-specific HLA antibodies following renal transplantation.
    Almeshari K; Pall A; Chaballout A; Elgamal H; Almana H; Alzayer F; Abaalkhail N; Altalhi M
    Clin Transpl; 2011; ():395-400. PubMed ID: 22755437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation.
    Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE
    Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-mediated rejection.
    Kittleson MM; Kobashigawa JA
    Curr Opin Organ Transplant; 2012 Oct; 17(5):551-7. PubMed ID: 22890038
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significance of low-level DSA detected by solid-phase assay in association with acute and chronic antibody-mediated rejection.
    Hirai T; Kohei N; Omoto K; Ishida H; Tanabe K
    Transpl Int; 2012 Sep; 25(9):925-34. PubMed ID: 22764746
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of vimentin antibody and other non-HLA antibodies with treated antibody mediated rejection in heart transplant recipients.
    Zhang X; Levine R; Patel JK; Kittleson M; Czer L; Kobashigawa JA
    Hum Immunol; 2020 Dec; 81(12):671-674. PubMed ID: 33041085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of Antibody-Mediated Rejection After Kidney Transplantation: Immunological Effects, Clinical Response, and Histological Findings.
    de Sousa MV; Gonçalez AC; de Lima Zollner R; Mazzali M
    Ann Transplant; 2020 Nov; 25():e925488. PubMed ID: 33199675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Desensitization Before Living Donor Kidney Transplantation in Highly HLA-Sensitized Patients: A Single-Center Study.
    De Sousa-Amorim E; Revuelta I; Blasco M; Diekmann F; Cid J; Lozano M; Sánchez-Escuredo A; Martorell J; Palou E; Campistol JM; Oppenheimer F
    Transplant Proc; 2015 Oct; 47(8):2332-5. PubMed ID: 26518919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute Antibody-Mediated Rejection in Kidney Transplant Based on the 2013 Banff Criteria: Single-Center Experience in Uruguay.
    Nin M; Coitiño R; Kurdian M; Orihuela L; Astesiano R; Garau M; López D; Rievas G; Rodriguez I; González-Martínez F; Noboa O
    Transplant Proc; 2016 Mar; 48(2):612-5. PubMed ID: 27110014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preformed circulating HLA-specific memory B cells predict high risk of humoral rejection in kidney transplantation.
    Lúcia M; Luque S; Crespo E; Melilli E; Cruzado JM; Martorell J; Jarque M; Gil-Vernet S; Manonelles A; Grinyó JM; Bestard O
    Kidney Int; 2015 Oct; 88(4):874-87. PubMed ID: 26176829
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transplantation across previously incompatible immunological barriers.
    Magee CC
    Transpl Int; 2006 Feb; 19(2):87-97. PubMed ID: 16441356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of antibody-mediated rejection in transplantation.
    Sadaka B; Alloway RR; Woodle ES
    Surg Clin North Am; 2013 Dec; 93(6):1451-66. PubMed ID: 24206861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Desensitization protocols in immunized living donor kidney transplant recipients].
    Nocera A
    G Ital Nefrol; 2009; 26(4):499-515. PubMed ID: 19644839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.